Effect of differentiation on the leucine enkephalin-degrading soluble enzymes released by the K562(S) cell line
- PMID: 9357005
- DOI: 10.1023/a:1021949908582
Effect of differentiation on the leucine enkephalin-degrading soluble enzymes released by the K562(S) cell line
Abstract
Leu-enkephalin hydrolysis kinetics were measured in the presence of soluble supernatants obtained from cultures of the K562(S) leukaemic cell line. Under these conditions, the substrate is degraded with formation of two distinct patterns of the hydrolysis by-products: in one pattern, similar amounts of Tyr and Tyr-Gly are formed; in the other, only Tyr-Gly can be measured. Kinetic data suggest that soluble proteolyses are released by these cells, and that either dipeptidylaminopeptidases alone, or both aminopeptidases and dipeptidylaminopeptidases are involved in substrate hydrolysis. This alternation of hydrolysis patterns appears consistent with existing data on the heterogeneity of K562 cells. In contrast with these results, chromatographic separation of the soluble enzymes indicates the release of all three classes of proteolyses known to hydrolyze enkephalins: aminopeptidases, dipeptidylaminopeptidases and dipeptidylcarboxypeptidases. In cells induced to differentiate by treatment with butyric acid, substrate hydrolysis is increased, and the pattern of the enzymes released is modified. In these cells, variations in both total proteolytic activity, and ratio between the three enzyme classes mentioned above are only minor, while the ratio between the different enzyme species within each class is greatly modified. Data obtained suggest that the expression of soluble enzymes is modified by differentiation. These data may also be interpreted as stressing the role of competition in controlling substrate hydrolysis by the multiple enzymes co-released by K562(S) cells.
Similar articles
-
Hydrolysis and association of leucine enkephalin to lymphomic and erythroleukaemic cell lines--III. Soluble enzymes.Int J Immunopharmacol. 1992 Aug;14(6):995-1002. doi: 10.1016/0192-0561(92)90143-9. Int J Immunopharmacol. 1992. PMID: 1428373
-
Effect of stimulation on soluble proteolytic enzymes released by peripheral blood mononuclear cells.Int J Immunopharmacol. 1993 Jul;15(5):621-9. doi: 10.1016/0192-0561(93)90080-i. Int J Immunopharmacol. 1993. PMID: 8375944
-
Soluble proteolytic enzyme release by naive and HIV-infected cultured T-cells.Int Immunopharmacol. 2003 May;3(5):615-26. doi: 10.1016/S1567-5769(02)00112-1. Int Immunopharmacol. 2003. PMID: 12757732
-
Soluble enkephalin-degrading enzymes released by lymphomic and erythroleukaemic cell lines.Neurochem Res. 1992 Nov;17(11):1155-61. doi: 10.1007/BF00967294. Neurochem Res. 1992. PMID: 1461363
-
[Chemical control of cell differentiation of human myeloleukemia K562 cell line].Yakugaku Zasshi. 2000 Jan;120(1):104-12. doi: 10.1248/yakushi1947.120.1_104. Yakugaku Zasshi. 2000. PMID: 10655786 Review. Japanese.
Cited by
-
An immunomodulating peptide with potential to suppress tumour growth and autoimmunity.Sci Rep. 2023 Nov 13;13(1):19741. doi: 10.1038/s41598-023-47229-y. Sci Rep. 2023. PMID: 37957274 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical